Ceftriaxone Adverse Events and its Extraction from Body Fluids: Review

References

[1] G Shalviri , S Yousefian, K Gholami,(2011 Nov 28.)“Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre,” PubmedSci. [online] https://pubmed.ncbi.nlm.nih.gov/22122488

[2] Vijay B. Arumugham , Rahul Gujarathi , Marco Cascella ,(2019) “Third Generation Cephalosporins” Treasure Island (FL): Stat Pearls Publishing [online] Third Generation Cephalosporins - PubMed (nih.gov)

[3] V. K. Ahluwalia & Madhu Chopra. “Medical Chemistry” ANE BOOKS INDIA.

[4] Clémence Lacroix , Annie-Pierre Bera-Jonville , François Montastruc ,Lionel Velly , Joëlle Micallef and Romain Guilhaumou,(May 2021) “Serious Neurological Adverse Events of Ceftriaxone”MDPIScientific journal publisher Serious Neurological Adverse Events of Ceftriaxone - PubMed (nih.gov)

[5] K. Tirgar-Fakheri, H. Ahangari (Sept-Oct 2006), “A Die Due to Ceftriaxone”,ANSI.net Journal of Medical Sciences A Die Due to Ceftriaxone-A Case Report (scialert.net)

[6] Ki Bae Kim, Sun Moon Kim, Woori Park, Ji Seon Kim, Soon Kil Kwon, Hye-Young Kim,(2012 Sep) “Ceftriaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review” Journal of Korean medical science. Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review - PubMed (nih.gov)

[7] Paolo Ruzza, Giuliano Siligardi, Rohanah Hussain, Anna Marchiani, Mehmet Islami, Luigi Bubacco, Giovanna Delogu, Davide Fabbri,∥ Maria A. Dettori,∥ Mario Sechi, Nicolino Pala, Ylenia Spissu, Rossana Migheli, Pier A. Serra, and GianPietro Sechi.,(Jan 2014) “Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro”,Pubmed journal Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro - PubMed (nih.gov)

[8] Guo, Y.. “Long-term use of ceftriaxone sodium- induced changes in gut microbiota and immune system”.( (2017) Pubmed journal Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system - PubMed (nih.gov)

[9] Nosheen Nasir , Sara Ahmed , Samrah Razi , Safia Awan , Syed Faisal Mahmood (Sept 2019)“Risk factors for mortality of patients with ceftriaxone-resistant E. coli bacteremia receiving carbapenem versus beta-lactam/beta- lactamase inhibitor therapy” Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy - PubMed (nih.gov)

[10] F. M. DEMOTES -MAINARD, * G. A. VINSON, C. H. JARRY and H. C. ALBIN (1988) “Micro method for determination of ceftriaxone in plasma and urine by high- performance liquid chromatography” Journal of Pharmaceutical & Biomedical Analysis Micromethod for determination of ceftriaxone in plasma and urine by high-performance liquid chromatography - PubMed (nih.gov)

[11] D M Richards, R C Heel, R N Brogden, T M Speight, G S Avery (June 1984),“Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.” ResearchGate journal Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use - PubMed (nih.gov)

[12] Boubakar Ba, Karen Gaudin, Amélie Désiré, Thida Phoeung, Marie-Hélène Langlois, Charan R Behl, Joel Unowsky, Indravadan H Patel, A Waseem Malick, Melba Gomes, Nicholas White, Tina Kauss ,(Nov 2018 ) “Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions” ResearchGate journal Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions - PubMed (nih.gov)

[13] Andrey B. LarichevAnna V. SmirnovaNatalya A. Slobodskaya,(Jan 2022) “Verification of ceftriaxone and determination of its concentration in blood serum by capillary electrophoresis in surgical patients” ResearchGate Verification of ceftriaxone and determination of its concentration in blood serum by capillary electrophoresis in surgical patients (researchgate.net)

[14] Magda A. Akl, Mona A. Ahmed, Ahmed Ramadan,(2011) “Validation of an HPLC-UV method for the determination of ceftriaxone sodium residues on stainless steel surface of pharmaceutical manufacturing equipment” J Pharm Biomed Anal.Validation of an HPLC- UV method for the determination of ceftriaxone sodium residues on stainless steel surface of pharmaceutical manufacturing equipments - PubMed (nih.gov)

[15] Ceftriaxone | C18H18N8O7S3 - PubChem (nih.gov). Ceftriaxone | C18H18N8O7S3 - PubChem (nih.gov)

@article{1704113,
      author = {Sarang S. Damle, Manjushri S. Bagul},
      title = {Ceftriaxone Adverse Events and its Extraction from Body Fluids: Review},
      journal = {Iconic Research And Engineering Journals},
      year = {2023},
      volume = {6},
      number = {8},
      pages = {156-160},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1704113.pdf},
      abstract = {Ceftriaxone also called ceftriaxone/Rocephin third-generation cephalosporin mainly works against bacterial infection in the human body. Ceftriaxone is a beta-lactam stable antibiotic drug that mainly works on the principle of cell destruction cell using inhibition of peptidoglycan synthesis. Ceftriaxone works against both gram-positive and gram-negative classes of bacterial infections such as infections caused by prevotella, streptococcus, and E. coli. There are some known adverse effects but in rare cases, those are seen in a very aggressive manner. Forensically such drug extraction is crucial for purpose of toxicological and chemical analysis from body fluids found on the scene of the crime. Different types of extraction processes are used for drugs from body fluids such as SPE-GC, and SPE-MS/ HPLC.},
      keywords = {Cephalosporin, E. coli, Gram-positive bacteria, SPE-GC (Solid Phase Extraction-Gas Chromatography},
      month = {February},
  }